US equities
|
SPCX
$168.46
▲+5.98%
NVDA
$237.30
▲+1.43%
MU
$1,066.49
▼-0.78%
TSLA
$378.81
▲+2.22%
MSFT
$525.43
▲+1.53%
SNDK
$1,714.48
▼-0.32%
INTC
$117.24
▼-1.75%
META
$742.92
▲+2.04%
SPCX
$168.46
▲+5.98%
NVDA
$237.30
▲+1.43%
MU
$1,066.49
▼-0.78%
TSLA
$378.81
▲+2.22%
MSFT
$525.43
▲+1.53%
SNDK
$1,714.48
▼-0.32%
INTC
$117.24
▼-1.75%
META
$742.92
▲+2.04%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Alpha Cognition Inc. - Common Stock
(NQ:
ACOG
)
9.030
-0.070 (-0.77%)
Delayed Quote
Updated: 1:14 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Alpha Cognition Inc. - Common Stock
< Previous
1
2
3
Next >
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2026
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition Announces CONVERGE Real-World Evidence on ZUNVEYL®(Benzgalantamine) Use in Long-Term Care
October 01, 2026
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 09, 2026
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition (NASDAQ:ACOG) Q1 Revenue Meets Estimates as Commercial Momentum Builds
↗
May 14, 2026
Via
Chartmill
Alpha Cognition Inc. (NASDAQ:ACOG) Reports Q4 Revenue Miss Amid Strong Alzheimer's Drug Launch
↗
March 26, 2026
Via
Chartmill
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 01, 2026
From
Alpha Cognition Inc.
Via
Business Wire
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) 2Q26
August 17, 2026
Dallas, Texas--(Newsfile Corp. - August 17, 2026) - Alpha Cognition Inc. (NASDAQ: ACOG): Stonegate Capital Partners updates their coverage on...
Via
Newsfile
Alpha Cognition (ACOG) Q2 2026 Earnings Call Transcript
↗
August 13, 2026
ZUNVEYL revenue surged 71% sequentially as repeat prescriber rates hit 76%.
Via
The Motley Fool
Topics
Earnings
Alpha Cognition Q2 Earnings Call Highlights
↗
August 13, 2026
Alpha Cognition (NASDAQ:ACOG) reported second-quarter 2026 net product revenue of approximately $6 million from its Alzheimer’s treatment ZUNVEYL, up about 71% sequentially from $3.5 million in the...
Via
MarketBeat
Topics
Earnings
Alpha Cognition Q2 2026 Earnings Call Transcript
↗
August 13, 2026
Alpha Cognition (NASDAQ:ACOG) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by...
Via
Benzinga
Topics
Earnings
Alpha Cognition Inc. Reports Second Quarter 2026 Financial Results and Provides Operational Update
August 13, 2026
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition to Report Second Quarter 2026 Financial Results and Provide Business Update
August 03, 2026
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer’s Disease
July 29, 2026
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition to Participate in Panel Discussion at the B. Riley Securities Mind, Muscle & Vision Summit
July 10, 2026
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board
June 23, 2026
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition Announces First Patient Enrolled in RESOLVE Phase 4 Study Evaluating ZUNVEYL® in Patients with Mild to Moderate Alzheimer’s Disease
June 16, 2026
From
Alpha Cognition, Inc.
Via
Business Wire
Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer’s Disease
June 09, 2026
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition Q1 Earnings Call Highlights
↗
May 14, 2026
Alpha Cognition (NASDAQ:ACOG) reported 40% sequential revenue growth in the first quarter of 2026, as executives said commercial adoption of its Alzheimer’s treatment ZUNVEYL continued to build across...
Via
MarketBeat
Topics
Earnings
Alpha Cognition (ACOG) Q1 2026 Earnings Transcript
↗
May 14, 2026
Alpha Cognition (ACOG) Q1 2026 Earnings Transcript
Via
The Motley Fool
Topics
Intellectual Property
Alpha Cognition Inc. Reports First Quarter 2026 Financial Results and Provides Operational Update
May 14, 2026
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition (Nasdaq: ACOG) to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, May 14, 2026
April 28, 2026
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition Inc. to Participate in Three Upcoming Investor Conferences
April 27, 2026
From
Alpha Cognition, Inc.
Via
Business Wire
Alpha Cognition Strengthens Its Board of Directors with Appointment of Bethany Sensenig
April 20, 2026
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 15, 2026
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury
April 01, 2026
From
Alpha Cognition Inc.
Via
Business Wire
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q425
April 01, 2026
Dallas, Texas--(Newsfile Corp. - April 1, 2026) - Alpha Cognition Inc. (NASDAQ: ACOG): Stonegate Capital Partners updates their coverage on...
Via
Newsfile
Alpha Cognition (ACOG) Q4 2025 Earnings Transcript
↗
April 01, 2026
Alpha Cognition (ACOG) Q4 2025 Earnings Transcript
Via
The Motley Fool
Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update
March 26, 2026
From
Alpha Cognition Inc.
Via
Business Wire
Water Giant With $7 Billion in Revenue Draws $7.5 Million Investment, and Shares Are Surging This Year
↗
March 15, 2026
This water solutions provider serves both consumers and businesses through recurring sales and a broad portfolio of regional brands.
Via
The Motley Fool
Payments Stock Down 30% Draws $6 Million Bet as Company Posts $4 Billion in Revenue
↗
March 15, 2026
Euronet Worldwide runs a global payments platform, providing transaction processing and money transfer solutions across diverse markets.
Via
The Motley Fool
< Previous
1
2
3
Next >
